4.8 Article

Regenerative Metaplastic Clones in COPD Lung Drive Inflammation and Fibrosis

期刊

CELL
卷 181, 期 4, 页码 848-+

出版社

CELL PRESS
DOI: 10.1016/j.cell.2020.03.047

关键词

-

资金

  1. Cancer Prevention Research Institute of Texas (CPRIT) [RR150104, RR1550088]
  2. National Institutes of Health [1R01DK115445-01A1, 1R01CA241600-01, U24CA228550, R01 DK047967, 5R01 HL138510, P01 HL108808, R01 HL136961, R01 HL129795, 1R01 HL136370-01A1]
  3. U.S. Department of Defense [W81XWH-17-1-0123]
  4. American Gastroenterological Association Research and Development Pilot Award in Technology
  5. Cystic Fibrosis Foundation [BOUCHE15R0, DICKEY18G0]

向作者/读者索取更多资源

Chronic obstructive pulmonary disease (COPD) is a progressive condition of chronic bronchitis, small airway obstruction, and emphysema that represents a leading cause of death worldwide. While inflammation, fibrosis, mucus hypersecretion, and metaplastic epithelial lesions are hallmarks of this disease, their origins and dependent relationships remain unclear. Here we apply single-cell cloning technologies to lung tissue of patients with and without COPD. Unlike control lungs, which were dominated by normal distal airway progenitor cells, COPD lungs were inundated by three variant progenitors epigenetically committed to distinct metaplastic lesions. When transplanted to immunodeficient mice, these variant clones induced pathology akin to the mucous and squamous metaplasia, neutrophilic inflammation, and fibrosis seen in COPD. Remarkably, similar variants pre-exist as minor constituents of control and fetal lung and conceivably act in normal processes of immune surveillance. However, these same variants likely catalyze the pathologic and progressive features of COPD when expanded to high numbers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据